In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-23 of 23 for your search:
Drug:  mesna
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2010-0065, NCI-2012-01779, NCT01169636

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 60 and over
Sponsor: Other
Protocol IDs: 2010-0991, NCI-2011-01123, NCT01371630

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Approved-not yet active
Age: 14 and over
Sponsor: NCI, Other
Protocol IDs: 2009-0471, NCT01740557

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Approved-not yet active
Age: 2 to 65
Sponsor: Other
Protocol IDs: 2012-0708, NCT01904136

5.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 64
Sponsor: Other
Protocol IDs: UMIAMI-20080803, SCCC-2008043, EPROST-20080803, NCT00878254

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 0 to 65
Sponsor: Other
Protocol IDs: 2009-0266, NCT01010217

7.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008-0598, NCT01319981

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: UCBT01, NCT01328496

9.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2009-0796, NCI-2011-01068, NCT01329900

10.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: LMTG 11-02, NCT01333605

11.

Phase: Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2010-0708, NCI-2011-01061, NCT01363128

12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: PLRG8 (OMB114361), 2010-023568-42, NCT01481272

13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: MC1184, NCI-2012-01061, NCT01670084

14.

Phase: Phase II
Type: Treatment
Status: Active
Age: 40 and under
Sponsor: Other
Protocol IDs: GEIS-21, 2009-016027-62, NCT01696669

15.

Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: PUMCH-S464, NCT01749072

16.

Phase: Phase II
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: HAPNK1, NCT01807611

17.

Phase: Phase II
Type: Treatment
Status: Active
Age: Under 19
Sponsor: Other
Protocol IDs: NB2012, NCT01857934

18.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 13-074, NCT01873326

19.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 70
Sponsor: Other
Protocol IDs: EORTC-1202, 2012-003672-39, cabazL06470, NCT01913652

20.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2013-0367, NCT02106988

21.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2012-0183, NCI-2012-00847, NCT01590732

22.

Phase: Phase I
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other, Pharmaceutical / Industry
Protocol IDs: MCC-17429, NCT01909206

23.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 30 and under
Sponsor: NCI, Other
Protocol IDs: ANBL12P1, COG-ANBL12P1, NCI-2012-02211, U10CA098543, NCT01798004
New Search